Authors

• Inderjit Mehmi (ORCID: https://orcid.org/0000-0002-2253-2206)
• Ryan J. Sullivan (ORCID: https://orcid.org/0000-0001-5344-6645)
• Omid Hamid (ORCID: https://orcid.org/0000-0002-8238-4655)
• Michael S. Caplan (ORCID: https://orcid.org/0000-0003-3498-3503)
• Marlana Orloff (ORCID: https://orcid.org/0000-0001-9460-2587)
• Antoine Desîlets (ORCID: https://orcid.org/0000-0002-9382-7597)
• Alexander Noor Shoushtari (ORCID: https://orcid.org/0000-0002-8065-4412)
• Rino S. Seedor (ORCID: https://orcid.org/0000-0002-8494-3289)
• Theodore Sunki Hong (ORCID: https://orcid.org/0000-0001-8481-6581)
• Kamaneh Montazeri (ORCID: https://orcid.org/0000-0003-3693-5994)
• Eric Wehrenberg-Klee (ORCID: https://orcid.org/0000-0002-4712-3986)
• Benjamin Izar (ORCID: https://orcid.org/0000-0003-2379-6702)
• Takami Sato (ORCID: https://orcid.org/0000-0003-2221-0415)
• Mariam El-Ashmawy (ORCID: https://orcid.org/0000-0002-2335-4827)
• Richard D. Carvajal (ORCID: https://orcid.org/0000-0002-3796-1118)
• Aleigha Lawless (ORCID: https://orcid.org/0009-0009-3861-3164)
• Shaheer Khan (ORCID: https://orcid.org/0000-0003-3963-0280)
• Tristan Lim (ORCID: https://orcid.org/0000-0002-3798-5400)

Institutions

• Northwell Health (US)
• Memorial Sloan Kettering Cancer Center (US)
• Thomas Jefferson University (US)
• Columbia University Irving Medical Center (US)
• Massachusetts General Hospital (US)
• Angeles Clinic and Research Institute (US)
• Sidney Kimmel Cancer Center (US)

Publication Details

Journal

The Oncologist

Published

2025-09-29

DOI

https://doi.org/10.1093/oncolo/oyaf323

Citations

3

Primary Topic

Ocular Oncology and Treatments

Type

article

Field-Weighted Citation Impact

5.12

Funders

• Amgen
• Bristol-Myers Squibb
• AstraZeneca
• GlaxoSmithKline
• Massachusetts General Hospital
• Regeneron Pharmaceuticals
• Exelixis
• Eisai
• Université de Montréal